| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |